AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

QinetiQ Group PLC

Director's Dealing Mar 20, 2020

4849_dirs_2020-03-20_97f642ef-efbe-4da9-a318-6c0586ee66b7.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0013H

QinetiQ Group plc

20 March 2020

QinetiQ Group plc (the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them

1. Details of PDMR / person closely associated with them ("PCA")
(a) Name David Smith
2. Reason for the notification
(a) Position / status Chief Financial Officer/Director
(b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a) Name QinetiQ Group plc
(b) Legal Entity Identifier Code 213800S8OBDOZMCMUW34
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a) Description of the financial instrument

Identification code
QinetiQ Group plc ordinary shares of 1 pence

GB00B0WMWD03
(b) Nature of the transaction Purchase of shares
(c) Price(s) and volume(s) Price(s) Volume(s)
£2.5278 15,705
(d) Aggregated information

-     Price

-     Volume

-     Total
£2.5278

15,705

£39,699.10
(e) Date of the transaction 2020-03-19
(f) Place of the transaction London Stock Exchange - XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHSEAFSSESSEFD

Talk to a Data Expert

Have a question? We'll get back to you promptly.